We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.36%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$657M
AUM Growth
+$275M
Cap. Flow
+$250M
Cap. Flow %
38.11%
Top 10 Hldgs %
46.95%
Holding
2,266
New
348
Increased
793
Reduced
382
Closed
125

Sector Composition

Rank Sector Weight
1 Financials 14%
2 Technology 12.89%
3 Consumer Discretionary 4.89%
4 Healthcare 4.71%
5 Communication Services 3.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMRC
2076
Commerce.com Inc Series 1
CMRC
$184M
$0 ﹤0.01%
8
BIPC icon
2077
Brookfield Infrastructure
BIPC
$4.85B
-9
Closed
BIT icon
2078
BlackRock Multi-Sector Income Trust
BIT
$702M
-2,115
Closed -$40K
BLFS icon
2079
BioLife Solutions
BLFS
$1.7B
$0 ﹤0.01%
9
BLOK icon
2080
Amplify Blockchain Technology ETF
BLOK
$1.07B
$0 ﹤0.01%
1
BOC icon
2081
Boston Omaha
BOC
$436M
-450
Closed -$14.7K
BTAI icon
2082
BioXcel Therapeutics
BTAI
$27.8M
-125
Closed -$61K
BTA
2083
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
$0 ﹤0.01%
+5
New +$70
CDZI icon
2084
Cadiz
CDZI
$291M
-288
Closed -$2K
CG icon
2085
Carlyle Group
CG
$17.2B
-218
Closed -$10K
CHPT icon
2086
ChargePoint
CHPT
$161M
$0 ﹤0.01%
+1
New +$443
CLDX icon
2087
Celldex Therapeutics
CLDX
$3.28B
-990
Closed -$53K
CLVT icon
2088
Clarivate
CLVT
$1.16B
$0 ﹤0.01%
+11
New +$255
COUR icon
2089
Coursera
COUR
$1.54B
$0 ﹤0.01%
10
-40
-80% -$1.22K
CRDF icon
2090
Cardiff Oncology
CRDF
$77.2M
-1,700
Closed -$11K
CRIS icon
2091
Curis
CRIS
$7.83M
-20
Closed -$63K
CRNC icon
2092
Cerence
CRNC
$413M
$0 ﹤0.01%
6
-134
-96% -$11.8K
CRVS icon
2093
Corvus Pharmaceuticals
CRVS
$1.17B
-14,000
Closed -$68K
CTSO icon
2094
Cytosorbents Corp
CTSO
$22.6M
-125
Closed -$1K
DCBO
2095
Docebo
DCBO
$566M
-130
Closed -$9.35K
DCTH icon
2096
Delcath Systems
DCTH
$524M
$0 ﹤0.01%
9
DEEP icon
2097
Acquirers Small and Micro Deep Value ETF
DEEP
$28.6M
$0 ﹤0.01%
1
DKNG icon
2098
DraftKings
DKNG
$11.9B
$0 ﹤0.01%
+10
New +$392
DLX icon
2099
Deluxe
DLX
$1.15B
$0 ﹤0.01%
9
DOMO icon
2100
Domo
DOMO
$184M
-14
Closed -$1K

Similar funds

Lindbrook Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Lindbrook Capital held 2,266 positions worth $657M, up 72% from $382M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Lindbrook Capital deployed $250M of net new capital in Q4 2021, opening 348 new positions and adding to 793 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 192,700 shares worth $10.9M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Morningstar Total Stock Market ETF, an estimated $1.92M trimmed.

  • Lindbrook Capital's largest Q4 2021 buy was iShares Core S&P Mid-Cap ETF: 192,700 shares worth $10.9M.
  • Lindbrook Capital added most to iShares Russell 1000 Growth ETF in Q4 2021, an estimated $29.7M increase.
  • Lindbrook Capital's biggest Q4 2021 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $1.92M.
  • Lindbrook Capital fully exited iShares MSCI South Korea ETF in Q4 2021, selling an estimated $93K.
  • Lindbrook Capital's ten largest holdings make up 47% of its $657M portfolio in Q4 2021.
  • Lindbrook Capital opened 348 new positions and closed 125 in Q4 2021.
  • Lindbrook Capital's portfolio value rose 72% quarter-over-quarter to $657M.

Based on Lindbrook Capital's 13F filing for Q4 2021, filed 18 Jan 2022.